Georgette Suidan

Cerevel Therapeutics, LLC

NIH Rank #3176
  • Early Career

NIH Funding · FY2024

Total Funding
$2.7M
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#3,176
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.7M across 1 grant · National rank #3176.

Top grants by award amount

Georgette Suidan's NIH grant portfolio, ranked by award amount.

  • 5UH3DA052166-03UH3
    CVL-354, a kappa opioid receptor antagonist for treatment of opioid use disorder, withdrawal and relapse
    $2.7M
    award amount

Affiliation

Institutions that have administered grants for Georgette Suidan.

Affiliated with Cerevel Therapeutics, LLC (MA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Cerevel Therapeutics, LLC
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3176
  6. 2024
    Entered Top 25% Nationally
    Ranked #3176